CORDIS
EU research results

CORDIS

English EN
Personalised Connected Care for Complex Chronic Patients

Personalised Connected Care for Complex Chronic Patients

Objective

The ambition of the CONNECARE consortium is to co-design, develop, deploy, and evaluate a novel smart, adaptive integrated care system for chronic care management. This will save European healthcare organisations huge sums whilst improving patient outcomes. The consortium contains all the necessary partners to ensure success.
Based on the concept of 4P medicine, CONNECARE will provide decision support for the adaptive management of personalised clinical pathways and will deliver tools to monitor patients’ activities and status, thus empowering them and providing them with recommendations to self-manage their condition, resulting in substantial improvements in their quality of life.
The three dimensions underpinning the required proposed paradigm shift are:
1. Organisational: making health and social care systems interoperable, promoting collaboration among care settings, and moving from institutional reactive care to a home-based preventive model.
2. Care and social services: addressing health risk prediction by combining already operational population-based tools with a patient-based five-dimension scoring strategy consisting of i) screening, ii) risk stratification, iii) mapping, iv) intervention, and v) surveillance.
3. Technological: delivering a CONNECARE system which leverages existing assets from partners to offer smart Adaptive Case Management, self-management and 3-level monitoring features, fully integrated with management systems in place.
An iterative patient-centred co-design process will ensure a progressive refinement of model and tools, providing foundations for adoption and transferability. In addition, clinical trials will be held in three leading-light regions in integrated care uptake –Catalonia, Israel, and Groningen – to evidence improvements in outcomes and efficiency. Consortium members are active in the EIP AHA B3 Action Group; transfer of results to relevant stakeholders across Europe, beyond the stakeholders in CONNECARE, is guaranteed.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

FUNDACIO EURECAT

Address

Avenida Universitat Autonoma 23
08290 Cerdanyola Del Valles (Barcelona)

Spain

Activity type

Research Organisations

EU Contribution

€ 904 725,75

Participants (9)

Sort alphabetically

Sort by EU Contribution

Expand all

CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

Spain

EU Contribution

€ 596 558

INSTITUT DE RECERCA BIOMEDICA DE LLEIDA FUNDACIO PRIVADA DOCTOR PIFARRE

Spain

EU Contribution

€ 469 375

ASSUTA MEDICAL CENTERS LTD

Israel

EU Contribution

€ 558 750

EWAVE LTD

Israel

EU Contribution

€ 580 000

ACADEMISCH ZIEKENHUIS GRONINGEN

Netherlands

EU Contribution

€ 530 850

IP HEALTH SOLUTIONS BV

Netherlands

EU Contribution

€ 133 775

UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA

Italy

EU Contribution

€ 297 062,50

TECHNISCHE UNIVERSITAET MUENCHEN

Germany

EU Contribution

€ 504 776,25

ADVANCED DIGITAL INNOVATION UK LTD

United Kingdom

EU Contribution

€ 388 316,25

Project information

Grant agreement ID: 689802

Status

Ongoing project

  • Start date

    1 April 2016

  • End date

    31 December 2019

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 4 964 188,75

  • EU contribution

    € 4 964 188,75

Coordinated by:

FUNDACIO EURECAT

Spain